Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 794

1.

Blood Culture Results Before and After Antimicrobial Administration.

Bush LM, Kaye D.

Ann Intern Med. 2020 Mar 17;172(6):439-440. doi: 10.7326/L19-0795. No abstract available.

PMID:
32176904
2.

Optimal Mechanical Unloading in Left Ventricular Assist Device Recipients Relates to Progressive Up-Titration in Pump Speed.

William J, Mak V, Leet A, Kaye DM, Nanayakkara S.

J Am Soc Echocardiogr. 2020 Mar 12. pii: S0894-7317(20)30010-9. doi: 10.1016/j.echo.2020.01.002. [Epub ahead of print]

PMID:
32173204
3.

Parental Perceptions About Alcohol Use for Their Adolescent with Attention-Deficit/Hyperactivity Disorder.

Harstad E, Sideridis G, Kaye D, Wisk LE, Weitzman ER, Levy S.

J Dev Behav Pediatr. 2020 Mar 11. doi: 10.1097/DBP.0000000000000794. [Epub ahead of print]

PMID:
32168259
4.

Management of heart failure with preserved ejection fraction.

Gard E, Nanayakkara S, Kaye D, Gibbs H.

Aust Prescr. 2020 Feb;43(1):12-17. doi: 10.18773/austprescr.2020.006. Epub 2020 Feb 3. Review.

5.

The Heart Failure with Preserved Ejection Fraction Conundrum-Redefining the Problem and Finding Common Ground?

Iyngkaran P, Thomas MC, Neil C, Jelinek M, Cooper M, Horowitz JD, Hare DL, Kaye DM.

Curr Heart Fail Rep. 2020 Apr;17(2):34-42. doi: 10.1007/s11897-020-00454-2. Review.

PMID:
32112345
6.

Long-term survival following transcatheter mitral valve repair: Pooled analysis of prospective trials with the Carillon device.

Lipiecki J, Kaye DM, Witte KK, Haude M, Kapadia S, Sievert H, Goldberg SL, Levy WC, Siminiak T.

Cardiovasc Revasc Med. 2020 Feb 21. pii: S1553-8389(20)30082-8. doi: 10.1016/j.carrev.2020.02.012. [Epub ahead of print]

PMID:
32111559
7.

Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.

Kaye DM, Shihata W, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, Johnson C, Fiedler A, Donner D, Snelson M, Coughlan MT, Phillips S, Du XJ, El-Osta A, Drummond G, Lambert GW, Spector T, Valdes AM, Mackay CR, Marques FZ.

Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081. [Epub ahead of print]

PMID:
32093510
8.

Association Between Delivery System Structure and Intensity of End-of-Life Cancer Care.

Herrel LA, Zhu Z, Griggs JJ, Kaye DR, Dupree JM, Ellimoottil CS, Miller DC.

JCO Oncol Pract. 2020 Feb 18:JOP1900667. doi: 10.1200/JOP.19.00667. [Epub ahead of print]

PMID:
32069191
9.

Impact of a model of care for heart failure in-patients to reduce variation in care - a quality improvement project.

Hopper I, Easton K, Bader I, Campbell J, Busija L, Markey P, Bergin P, Kaye D.

Intern Med J. 2020 Feb 11. doi: 10.1111/imj.14783. [Epub ahead of print]

PMID:
32043694
10.

The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction.

Beale AL, Cosentino C, Segan L, Mariani JA, Vizi D, Evans S, Nanayakkara S, Kaye DM.

ESC Heart Fail. 2020 Feb;7(1):213-222. doi: 10.1002/ehf2.12557. Epub 2020 Jan 20.

11.

Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S, Prabhu S, Stub D, Azzopardi S, Vizi D, Wong G, Nalliah C, Sugumar H, Wong M, Kotschet E, Kaye D, Taylor AJ, Kistler PM.

N Engl J Med. 2020 Jan 2;382(1):20-28. doi: 10.1056/NEJMoa1817591.

PMID:
31893513
12.

A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia.

Liu H, Byrne M, Perlmutter P, Walker A, Sama GR, Subbiah J, Ozcelik B, Widdop RE, Gaspari TA, Byron K, Chen YC, Kaye DM, Dear AE.

Cardiovasc Drugs Ther. 2019 Dec;33(6):687-692. doi: 10.1007/s10557-019-06921-w.

PMID:
31885055
13.

Sex differences in heart failure.

Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, Ky B, Santema BT, Sliwa K, Voors AA.

Eur Heart J. 2019 Dec 14;40(47):3859-3868c. doi: 10.1093/eurheartj/ehz835.

PMID:
31800034
14.

Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.

Obokata M, Reddy YNV, Shah SJ, Kaye DM, Gustafsson F, Hasenfuβ G, Hoendermis E, Litwin SE, Komtebedde J, Lam C, Burkhoff D, Borlaug BA.

J Am Coll Cardiol. 2019 Nov 26;74(21):2539-2550. doi: 10.1016/j.jacc.2019.08.1062.

PMID:
31753198
15.

Effects of Operating Room Size on Surgical Site Infection Following Lumbar Fusion Surgery.

Salmons HI, Lendner M, Divi SN, Dworkin M, McKenzie J, Tarazona D, Gala Z, Lendner Y, Woods B, Kaye D, Savage J, Kepler C, Kurd M, Hsu V, Radcliff K, Rihn J, Anderson G, Hilibrand A, Vaccaro A, Schroeder G.

Int J Spine Surg. 2019 Oct 31;13(5):423-428. doi: 10.14444/6057. eCollection 2019 Oct.

16.

Relationship of Degree of Systolic Dysfunction to Variations in Exercise Capacity and Hemodynamic Status in HFpEF.

Nanayakkara S, Telles F, Beale AL, Evans S, Vizi D, Marwick TH, Kaye DM.

JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):528-530. doi: 10.1016/j.jcmg.2019.09.016. Epub 2019 Nov 13. No abstract available.

PMID:
31734204
17.

Impaired l-arginine-nitric oxide pathway contributes to the pathogenesis of resistant hypertension.

Rajapakse NW, Giam B, Kuruppu S, Head GA, Kaye DM.

Clin Sci (Lond). 2019 Oct 30;133(20):2061-2067. doi: 10.1042/CS20190851.

PMID:
31654065
18.

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).

Hanff TC, Kaye DM, Hayward CS, Post MC, Malek F, Hasenfuβ G, Gustafsson F, Burkhoff D, Shah SJ, Litwin SE, Kahwash R, Hummel SL, Borlaug BA, Solomon SD, Lam CSP, Komtebedde J, Silvestry FE; REDUCE LAP-HF study investigators, and research staff.

Am J Cardiol. 2019 Dec 15;124(12):1912-1917. doi: 10.1016/j.amjcard.2019.09.019. Epub 2019 Sep 26.

PMID:
31653352
19.

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction.

Kaye DM, Nanayakkara S.

Front Cardiovasc Med. 2019 Sep 18;6:143. doi: 10.3389/fcvm.2019.00143. eCollection 2019. Review.

20.

Iron Deficiency in Acute Decompensated Heart Failure.

Beale A, Carballo D, Stirnemann J, Garin N, Agoritsas T, Serratrice J, Kaye D, Meyer P, Carballo S.

J Clin Med. 2019 Oct 1;8(10). pii: E1569. doi: 10.3390/jcm8101569.

21.

Medicaid Reimbursement for Common Spine Procedures: Are Compensation Rates Consistent?

Casper DS, Schroeder GD, McKenzie J, Zmistowski B, Vatson J, Mangan J, Stull J, Kurd M, Rihn JA, Anderson DG, Kaye DI, Radcliff K, Woods B, Hilibrand AS, Vaccaro AR, Kepler CK.

Spine (Phila Pa 1976). 2019 Nov 15;44(22):1585-1590. doi: 10.1097/BRS.0000000000003241.

PMID:
31568265
22.

Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis.

Mahajan R, Stokes M, Elliott A, Munawar DA, Khokhar KB, Thiyagarajah A, Hendriks J, Linz D, Gallagher C, Kaye D, Lau D, Sanders P.

Heart. 2020 Jan;106(1):58-68. doi: 10.1136/heartjnl-2019-314770. Epub 2019 Sep 17.

PMID:
31530572
23.

The Baker Biobank: Understanding Cardiovascular Outcomes.

Haregu TN, Nanayakkara S, Kingwell B, Jennings G, Dart A, Carrington M, Kaye D.

Heart Lung Circ. 2019 Sep 9. pii: S1443-9506(19)31419-2. doi: 10.1016/j.hlc.2019.08.014. [Epub ahead of print]

PMID:
31526682
24.

The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation.

Witte KK, Lipiecki J, Siminiak T, Meredith IT, Malkin CJ, Goldberg SL, Stark MA, von Bardeleben RS, Cremer PC, Jaber WA, Celermajer DS, Kaye DM, Sievert H.

JACC Heart Fail. 2019 Nov;7(11):945-955. doi: 10.1016/j.jchf.2019.06.011. Epub 2019 Sep 11.

25.

The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications.

Kaye DK.

Philos Ethics Humanit Med. 2019 Sep 6;14(1):11. doi: 10.1186/s13010-019-0081-8. Review.

26.

Non-invasive blood pressure monitoring underestimates hypertensive response to exercise in suspected heart failure with preserved ejection fraction.

Cieslik LK, Patel HC, Steele SJ, Beale AL, Tan CN, Mariani JA, Nanayakkara S, Kaye DM.

Eur J Prev Cardiol. 2019 Sep 3:2047487319873452. doi: 10.1177/2047487319873452. [Epub ahead of print] No abstract available.

PMID:
31480876
27.

A Single-Center Experience of the Optimal Initial Immunosuppressive Strategy for Preventing Early Acute Cellular Rejection in Orthotopic Heart Transplantation Associated With Renal Dysfunction.

Mundisugih J, Fernando H, Bergin P, Hare J, Kaye D, Leet A, McGiffin D, Taylor AJ.

Prog Transplant. 2019 Dec;29(4):327-334. doi: 10.1177/1526924819873908. Epub 2019 Sep 2.

PMID:
31476958
28.

Use of Colistin in Critically Ill Patients.

Marchaim D, Kaye D, Kaye KS.

Adv Exp Med Biol. 2019;1145:155-179. doi: 10.1007/978-3-030-16373-0_12. Review.

PMID:
31364078
29.
30.

Impact of Sex on Ventricular-Vascular Stiffness and Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial Substudy.

Beale AL, Nanayakkara S, Kaye DM.

J Am Heart Assoc. 2019 Jul 2;8(13):e012190. doi: 10.1161/JAHA.119.012190. Epub 2019 Jun 22.

31.

Venoarterial extracorporeal membrane oxygenation: A systematic review of selection criteria, outcome measures and definitions of complications.

Burrell AJC, Bennett V, Serra AL, Pellegrino VA, Romero L, Fan E, Brodie D, Cooper DJ, Kaye DM, Fraser JF, Hodgson CL; International ECMO Network (ECMONet).

J Crit Care. 2019 Oct;53:32-37. doi: 10.1016/j.jcrc.2019.05.011. Epub 2019 May 24.

PMID:
31181462
32.

Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention.

Warren J, Nanayakkara S, Andrianopoulos N, Brennan A, Dinh D, Yudi M, Clark D, Ajani AE, Reid CM, Selkrig L, Shaw J, Hiew C, Freeman M, Kaye D, Kingwell BA, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators.

J Am Coll Cardiol. 2019 Jun 11;73(22):2846-2855. doi: 10.1016/j.jacc.2019.03.493.

PMID:
31171090
33.

Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D.

Open Heart. 2019 Apr 3;6(1):e001012. doi: 10.1136/openhrt-2019-001012. eCollection 2019.

34.

Reply: The Importance of Baseline Physical Activity Level in Heart Failure With Preserved Ejection Fraction.

Beale AL, Nanayakkara S, Kaye DM.

JACC Heart Fail. 2019 Jun;7(6):535-536. doi: 10.1016/j.jchf.2019.03.013. No abstract available.

PMID:
31146881
35.
36.

The role of the gut microbiome in sex differences in arterial pressure.

Beale AL, Kaye DM, Marques FZ.

Biol Sex Differ. 2019 Apr 25;10(1):22. doi: 10.1186/s13293-019-0236-8. Review.

37.

Electrical Phenotype in Heart Failure With Preserved Ejection Fraction: Disease Severity Marker or Therapeutic Target?

Kaye DM, Patel HC.

JACC Heart Fail. 2019 May;7(5):428-430. doi: 10.1016/j.jchf.2019.02.005. Epub 2019 Apr 10. No abstract available.

PMID:
30981743
38.

Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.

Sugumar H, Nanayakkara S, Prabhu S, Voskoboinik A, Kaye DM, Ling LH, Kistler PM.

Cardiol Clin. 2019 May;37(2):131-138. doi: 10.1016/j.ccl.2019.01.002. Epub 2019 Feb 20. Review.

PMID:
30926014
39.

Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy.

Savira F, Magaye R, Hua Y, Liew D, Kaye D, Marwick T, Wang BH.

Toxicol Lett. 2019 Jun 15;308:34-49. doi: 10.1016/j.toxlet.2019.03.002. Epub 2019 Mar 11. Review.

PMID:
30872129
40.

Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology.

Normand C, Kaye DM, Povsic TJ, Dickstein K.

Lancet. 2019 Mar 9;393(10175):1045-1055. doi: 10.1016/S0140-6736(18)32216-5. Review.

PMID:
30860030
41.

Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.

Wolsk E, Kaye D, Komtebedde J, Shah SJ, Borlaug BA, Burkhoff D, Kitzman DW, Lam CSP, van Veldhuisen DJ, Ponikowski P, Petrie MC, Hassager C, Møller JE, Gustafsson F.

JACC Heart Fail. 2019 Apr;7(4):321-332. doi: 10.1016/j.jchf.2019.01.006. Epub 2019 Mar 6.

PMID:
30852235
42.

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy.

Chu PY, Joshi MS, Horlock D, Kiriazis H, Kaye DM.

Front Pharmacol. 2019 Feb 19;10:117. doi: 10.3389/fphar.2019.00117. eCollection 2019.

43.

Make a Joyful Noise: Integrating Music into Child Psychiatry Evaluation and Treatment.

Bostic JQ, Thomas CR, Beresin EV, Rostain AL, Kaye DL.

Child Adolesc Psychiatr Clin N Am. 2019 Apr;28(2):195-207. doi: 10.1016/j.chc.2018.11.003. Epub 2019 Feb 6. Review.

PMID:
30832952
44.

Resting and Exercise Doppler Hemodynamics: How and Why?

Nanayakkara S, Kaye DM, Marwick TH.

Heart Fail Clin. 2019 Apr;15(2):229-239. doi: 10.1016/j.hfc.2018.12.003. Epub 2019 Feb 2. Review.

PMID:
30832814
45.

Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.

Beale AL, Nanayakkara S, Segan L, Mariani JA, Maeder MT, van Empel V, Vizi D, Evans S, Lam CSP, Kaye DM.

JACC Heart Fail. 2019 Mar;7(3):239-249. doi: 10.1016/j.jchf.2019.01.004.

46.
47.

Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.

Ginsburg KB, Arcot R, Qi J, Linsell SM, Kaye DR, George AK, Cher ML; MUSIC.

J Urol. 2019 May;201(5):923-928. doi: 10.1097/JU.0000000000000059.

PMID:
30694939
48.

Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program.

Kaye DR, Dunn RL, Li J, Herrel LA, Dupree JM, Miller DC, Ellimoottil C.

J Surg Res. 2019 Apr;236:30-36. doi: 10.1016/j.jss.2018.09.073. Epub 2018 Dec 4.

PMID:
30694769
49.

Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction.

Telles F, Nanayakkara S, Evans S, Patel HC, Mariani JA, Vizi D, William J, Marwick TH, Kaye DM.

Eur J Heart Fail. 2019 Apr;21(4):495-505. doi: 10.1002/ejhf.1399. Epub 2019 Jan 16.

PMID:
30652393
50.

Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population.

Kaye DR, Luckenbaugh AN, Oerline M, Hollenbeck BK, Herrel LA, Dimick JB, Hollingsworth JM.

Ann Surg. 2020 Jan;271(1):23-28. doi: 10.1097/SLA.0000000000003165.

PMID:
30601252

Supplemental Content

Support Center